Elevance Health
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $45,442,000 | $45,145,000 | $43,646,000 | $42,577,000 |
Gross Profit | 45,442,000 | 12,196,000 | 13,074,000 | 12,031,000 |
EBITDA | 1,004,000 | 2,002,000 | 3,601,000 | 3,535,000 |
EBIT | 1,999,000 | 1,673,000 | 3,266,000 | 3,204,000 |
Net Income | 418,000 | 1,016,000 | 2,300,000 | 2,246,000 |
Net Change In Cash | 45,442,000 | 45,145,000 | 43,646,000 | 42,577,000 |
Free Cash Flow | 384,000 | 2,345,000 | 124,000 | 1,699,000 |
Cash | 8,288,000 | 7,866,000 | 6,497,000 | 6,226,000 |
Basic Shares | 231,100 | 233,100 | 233,400 | 234,200 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $176,810,000 | $171,340,000 | $156,595,000 | $138,639,000 |
Gross Profit | 157,060,000 | 47,010,000 | 39,953,000 | 35,994,000 |
EBITDA | 9,089,000 | 10,490,000 | 10,126,000 | 6,004,000 |
EBIT | 7,696,000 | 8,745,000 | 8,451,000 | 4,702,000 |
Net Income | 5,980,000 | 5,987,000 | 5,894,000 | 6,104,000 |
Net Change In Cash | 176,810,000 | 171,340,000 | 156,595,000 | 138,639,000 |
Cost of Revenue | 2,521,000 | -861,000 | ||
Free Cash Flow | 4,552,000 | 6,765,000 | 7,247,000 | 7,277,000 |
Cash | 8,288,000 | 6,526,000 | 7,387,000 | 4,880,000 |
Basic Shares | 232,900 | 237,400 | 242,800 | 246,800 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $3.84 |
2024-09-30 | $8.37 |
2024-06-30 | $10.12 |
2024-03-31 | $10.64 |
